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Abstract
The coronavirus disease, COVID-19, has changed daily life dramatically since early 2020. Although
COVID-19 vaccines are available in the United States, many express distrust in this primary prevention measure
and doubt both the seriousness of COVID-19 and its associated morbidity and mortality. Vaccine hesitancy, also
described as the reluctance or refusal of vaccines despite availability, exists on a continuum and was a known
public health threat prior to the coronavirus pandemic. This narrative review examines studies related to the
determinants of COVID-19 vaccine hesitancy among adults in the United States. Also explored are the factors
related to COVID-19 vaccine risk communication and available interventions to address COVID-19. Perceived
severity of and susceptibility to COVID-19, trust in public health authorities and government in general,
educational attainment, income, race, and sex were found to be significant determinants of vaccine hesitancy.
Due to lack of available evidence-based interventions to counter COVID-19 vaccine hesitancy, peer-reviewed
commentaries and other health communication principles formed the basis of additional recommendations for
COVID-19 vaccine hesitancy interventions. Recommendations included trust-building efforts at the community,
national, and institutional levels, as well as addressing social determinants of health. These findings may be
limited by recent vaccine mandates related to education and to employment. Future research is needed to identify
any changes in acceptance, uptake, and trust in institutions such as public health agencies and universities, and
representatives of those institutions.
Keywords: COVID-19, vaccine hesitancy, health communication, risk communication
The novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), also known as COVID19, radically changed the world since the public and the
public health community became aware of its
emergence. In most cases, the virus causes only mild
illness or can even be asymptomatic; however, it can
also lead to hospitalization and death. Sequelae
associated with COVID-19 include so-called “longhaul COVID” or post-COVID syndrome (PCS), and
multisystem inflammatory syndrome in children (MISC).
On March 13, 2020, then President Donald
Trump officially announced the COVID-19 pandemic

to warrant a state of emergency declaration (Federal
Emergency Management Agency). Since that time,
nearly 48 million cases have been identified, and over
776,000 American deaths have been reported and
counted as related to COVID-19, according to the
Johns Hopkins Coronavirus Resource Center (2021).
With these data, there is a calculated gross death rate
of 1.61% (776,639 ÷ 48,229,210 × 100 = 1.61).
According to the Centers for Disease Control and
Prevention (CDC) website, COVID-19 was given as
the underlying cause of death on at least 90% of
COVID-19 related death certificates, while the disease
was a contributing cause in the remaining fatalities.
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The most commonly reported comorbidities are related
to COVID-19 pathology: influenza and pneumonia.
Other common comorbidities not related to COVID-19
pathology are hypertension, listed in 18.8% of deaths,
and diabetes, listed in 15.5% of deaths (2021). Both of
these comorbidities are often related to social
determinants of health and modifiable lifestyle factors.
The COVID-19 pandemic has been
characterized by discord and sociopolitical
divisiveness, including controversy related to claims
that COVID-19 deaths have been exaggerated and that
confounding comorbidities have been underreported.
Such controversies began with the very nature of the
novel coronavirus itself and competing hypotheses
about its origin. In early 2020, the prevailing narrative
was that COVID-19 emerged from a wet market in
Wuhan, China, the epicenter of the pandemic. This
claim was supported by a letter published in the
venerable journal, The Lancet, which proclaimed its
purpose to be a public show of support for those
battling against the virus in China and “to strongly
condemn conspiracy theories suggesting that COVID19 does not have a natural origin” [emphasis mine]
(Calisher et al., 2020). In this context, critical thinking,
investigation, and debate were not worthy of
consideration. The document indicated that genomic
sequence analyses led to a scientific consensus
regarding the origin of the COVID-19 virus, and that
the mere suggestion of other theories posed a threat to
the public health response.
There is also the alternate hypothesis that the
pandemic may have originated from the Wuhan
Institute of Virology, where bat coronaviruses are
studied. Once widely dismissed as a patently untrue
conspiracy theory, this lab leak hypothesis has since
been revisited. The aforementioned letter published in
The Lancet was signed by Dr. Peter Daszak, president
of the EcoHealth Alliance. A nonprofit organization
based in the United States, EcoHealth Alliance
received $3.1 million of funding from the National
Institutes of Health (NIH) in the form of a 2014 grant
titled, “Understanding the Risk of Bat Coronavirus
Emergence.” The Wuhan Institute of Virology
received about $750,000 from this grant, and
experiments that were conducted there involving
humanized mice and genetically altered bat
coronaviruses have been scrutinized for possibly

qualifying as gain-of-function research, which can
potentially be dangerous. If pathogens are altered
through gain-of-function research to become more
transmissible and able to infect humans, a lapse in
safety protocols could lead to an outbreak among
laboratory personnel and potentially spread to the
general public. However, the NIH ruled that these
experiments did not qualify as restricted gain-offunction research (Hvistendahl & Lerner, 2021).
The lab leak hypothesis, mainstream media
coverage of COVID-19 cases and deaths, compulsory
business closures, mask-wearing, alternate therapies
such as hydroxychloroquine and ivermectin, and
vaccination are all political wedge issues related to
COVID-19. Vaccines that are currently available in the
United States are manufactured by Pfizer-BioNTech,
Moderna, and Johnson & Johnson (Janssen or J&J).
J&J is a single dose adenovirus vaccine while PfizerBioNTech, also known as Comirnaty (community +
mRNA + immunity), and Moderna vaccines are each a
series
of
two
mRNA
vaccines.
Current
recommendations from the CDC are that individuals
who are five years of age and older receive a COVID19 vaccination. The J&J vaccine has emergency use
authorization (EUA) from the Food and Drug
Administration (FDA) for those 18 and older. The
Pfizer-BioNTech vaccine has EUA for children ages 515, and Comirnaty has FDA approval for those 16 and
older. The Moderna vaccine is available under EUA for
those 18 and older. A third dose, or booster shot, from
any manufacturer is available two months postvaccination for those who received J&J and six months
later for those who received Moderna or PfizerBioNTech. Heterologous dosage or “mix and match” is
permitted. EUA for the Pfizer-BioNTech vaccine,
applicable to children ages 5-11, arrived in early
November (Centers for Disease Control and
Prevention, 2021a).
Despite freely available vaccines, COVID-19
vaccine hesitancy poses a considerable public health
threat. According to the Johns Hopkins Coronavirus
Resource Center, vaccination coverage ranges from
about 45% in Wyoming to over 81% in the District of
Columbia, with a national average of nearly 60%
(2021). Vaccine mandates have also become a source
of controversy, including the push of the Biden
Administration for mandatory COVID-19 vaccination
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or weekly testing for employers of 100 or more
workers. Such a rule would be considered a soft
mandate because it allows for vaccine-hesitant
individuals to be tested rather than having to decide
between being vaccinated or sacrificing their
livelihoods, although the time and financial burdens of
testing could be significant. Hard vaccine mandates
without a testing option exist for certain groups such as
healthcare workers. There are varying local, regional,
and organizational rules related to exemptions for
medical reasons, religious beliefs, and philosophical or
personal beliefs.
Within this context, there is a clear need to
identify the determinants of and evidence-based
interventions for COVID-19 vaccine hesitancy in the
U.S. As with other vaccine-preventable diseases,
unvaccinated individuals tend to cluster together and
experience avoidable outbreaks, such as the recent
measles outbreaks in the Orthodox Jewish
communities of New Jersey and New York (McDonald
et al., 2019). Children whose parents choose to eschew
COVID-19 vaccination for them may suffer
preventable, devastating consequences. Limited
vaccine coverage below the threshold for herd
immunity gives COVID-19 more opportunities to
replicate, mutate, and kill hosts: human beings with
passions, dreams, fears, and loved ones. It is the
purpose of this document to conduct a comprehensive
literature review for the current year, 2021, to identify
the determinants of and current interventions for
COVID-19 vaccine hesitancy in the United States, as
well as to provide recommendations for evidencebased interventions to reduce COVID-19 vaccine
hesitancy in the U.S.
Methods
This narrative review consists of the summaries
of relevant literature published in 2021, excluding
studies published in 2020 due to the rapidly changing
information environment. The population of interest is
U.S. adults. Three categories of literature will be
considered: studies with a focus on determinants of
COVID-19 vaccine hesitancy (category 1), studies
related to health and risk communication of vaccines
for COVID-19 available in the United States (category
2), and studies on interventions for COVID-19 vaccine
hesitancy with a focus on methodology (category 3).

The inclusion criteria are as follows:
1. Published in peer-reviewed journals in 2021
2. Studies conducted in 2021 (categories 1 and 2)
3. Discussion of determinants of COVID-19 vaccine
hesitancy (category 1 only)
4. Discussion of communication related to COVID19 vaccines available in the United States (category
2 only)
5. Discussion of interventions for COVID-19 vaccine
hesitancy (category 3 only)
6. Nationally representative sample of U.S.
population
7. Discoverable through Medline (PubMed Central)
and CINAHL
The exclusion criteria are as follows:
1. Pre-print articles
2. Studies published in languages other than English
3. Letters to the editor or other works of opinion
(category 1 only)
4. Samples not nationally representative of the U.S.
population (category 1 only)
5. Studies conducted in 2020 (category 1 only)
Discussion
The purpose of this narrative review was to
contribute to the ongoing research conversation related
to COVID-19 vaccine hesitancy, in service of reduced
morbidity and mortality, as well as to the ultimate goal
of COVID-19 elimination. The salient determinants
across different studies can be categorized as
individual-level, group-level, and community-level. At
the individual level, characteristics such as race,
ethnicity, sex, educational attainment, political
ideology, perception of risk, and income were found to
be significant in predicting COVID-19 vaccine
hesitancy. At the group level, factors such as avoidance
of crowds by family and friends seem to play a role.
Political ideology could be considered a factor at both
the individual and community levels due to the social
influence on values and belief systems.
Strengths of these data are their relative recency
and broad overview of the numerous demographic and
psychological factors which impact COVID-19
vaccine hesitancy. Since information related to the
coronavirus pandemic has been characterized by the
ever-present and ever-changing news environment, it
is the intention of this paper to provide the most current
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information. The large, nationally representative
samples involved would ideally capture the spectrum
of diversity of the U.S. population and the associated
diversity of opinions and values.
The
PICO
(population,
intervention,
comparator, outcomes - comparator not applicable) and
PEO (population, exposure, outcome) frameworks can
be used to conceptualize these findings, as the
fundamental nature of the research is informed by these
factors. The population of interest is U.S. adults.
Interventions could address risk communication
strategies, knowledge, ideological polarization, or risk
factors for vaccine hesitancy, such as low educational
attainment and low income. These demographic factors
may be associated with increased hesitancy due to
disenfranchisement and marginalization. Exposures
that may influence COVID-19 vaccine hesitancy
include knowledge of COVID-19 vaccines, philosophy
of health freedom, interactions with healthcare
workers, information related to COVID-19 infection
susceptibility risk and severity, as well as side effects
of the vaccine. Since hesitancy exists on a continuum,
the outcomes of interest would be COVID-19 vaccine
acceptance, reluctance, refusal, and uptake.
There was a significant overlap in the three
categories that were used for the literature review. For
instance, the searches for studies on risk
communication and interventions yielded results that
examined determinants of COVID-19 vaccine
hesitancy. Thus, studies were organized into category
1, Table 1 while articles best described as commentary
were distilled into category 2, Table 2, relating to risk
communication and interventions for COVID-19
vaccine hesitancy. These commentaries, though
sufficient for peer-reviewed journals, are susceptible to
personal biases and significant limitations.
Nonetheless, these are the basis of evidence until
formal interventions grounded in health promotion
theory and methodology are developed and deployed.
This narrative review can be replicated by searching
the PubMed and CINAHL databases for literature on
COVID-19 vaccine hesitancy from January-September
2021 and screening according to the inclusion and
exclusion criteria. The PRISMA flow diagrams
provide reference for the replication process.
Related to interventions specifically, there are
significant limitations. Unfortunately, there seems to

be a dearth of interventions deployed to address
COVID-19 vaccine hesitancy. The intention of this
narrative review at the outset was to identify evidencebased interventions and to organize the salient findings
with a focus on methodology. Since the interventionrelated literature available through PubMed is limited
to commentaries, thus far no precedent exists for
evidence-based interventions. Literature that does
discuss intervention methods tends to focus on
increasing acceptance and uptake for the COVID-19
vaccine through increased availability and
convenience, i.e., offering its administration at
pharmacies nationwide, decreased or eliminated
upfront cost, and mandatory vaccination for access to
certain situations, such as work and public education.
An additional limitation of these national
studies is their broad nature. For the instances when
vaccination status and intention are self-reported along
with demographic data, there is potential for
inaccuracies. The broad scope may omit the nuance
and distinctions which can be observed on a closer
level. This can be seen with demographic data in
particular. For example, there are a myriad of distinct
racial, ethnic, religious, and other types of subcultures
within the U.S. that are likely to be lost when the
research is national in scope. Limited research seems
to exist on the rates of vaccine hesitancy among
different faiths. Since the findings of this narrative
review indicate that female sex is associated with
greater rates of vaccine hesitancy, additional research
may wish to explore this area. Females may be less
risk-averse and could perhaps be more likely to be
making health decisions for themselves and for family
members, particularly children. Gender identity was
not included in most of the studies which were
reviewed. Looking to the future, there may be
opportunities for qualitative studies that explore
COVID-19 vaccine hesitancy in one-on-one interview
or group settings, particularly related to parents and
caregivers who make vaccination decisions for
children.
Recent vaccine mandates likely limit the
relevance of this narrative review. Future research may
wish to consider the impact of COVID-19 vaccine
mandates as a condition of employment, including
whether individuals who are dismissed for
noncompliance are able to collect unemployment
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insurance benefits and the possible impacts of this
policy decision on trust and political divisiveness.
COVID-19 vaccine hesitancy certainly does
not exist in a vacuum. Resistance to vaccination predated the novel coronavirus pandemic, and it will
almost certainly continue even if COVID-19 is fully
eradicated. Therefore, it may be helpful to consider the
broader sociopolitical context of this narrative review.
Trust in the public health establishment and more
generally, in the government, emerged as a consistent
theme held by those who expressed vaccine hesitancy,
as well as a theme in commentary related to risk
communication
and
recommendations
for
interventions.
Though innovative and effective, like all
vaccines, COVID-19 vaccines are not 100% effective
in preventing disease, hospitalization, or death, nor are
they 100% safe for every individual. As discussed by
Rosenbaum, to acknowledge such facts is to
acknowledge the nuances inherent to scientific reality
(2021b). A recent article from the CDC’s Morbidity
and Mortality Weekly Report indicates the declining
vaccine effectiveness for Pfizer-BioNTech, though the
three available vaccines all provide considerable
protection against hospitalization for COVID-19.
Specifically, the Pfizer-BioNTech was measured as
88% effective, with a reduction from 91% to 77%
effectiveness beyond 120 days post-vaccination (Self,
et al., 2021). In comparison, Moderna showed 93%
effectiveness and J&J, 71%. The differing
effectiveness shown by Pfizer-BioNTech and
Moderna, both mRNA vaccines, may be explained by
the greater amount of mRNA present in Moderna and
the differing time between the first and second doses:
four weeks for Moderna and three for Pfizer-BioNTech
(Self, et al., 2021). Much of the public believed or were
led to believe that vaccines would create virtually
impregnable protection against contracting the
coronavirus disease, but particularly against
hospitalization and death. Breakthrough cases and
deaths have been criticized, perhaps contributing to
diminished public trust in public health institutions and
the COVID-19 vaccines.
Furthermore, some of the skepticism regarding
the FDA is related to its funding. In November 2020,
the FDA reported that approximately 55% of its $5.9
billion budget is supplied through the federal budget

while 45% is provided by “industry user fees.” Since
33.0% of the total FDA budget is related to the
regulation of human drugs, critics have raised concerns
related to a possible conflict of interest, claiming that a
regulatory body is not entirely impartial if dependent
on the funds of the businesses for which it provides
oversight.
Similarly, public distrust is likely also
associated with medical and pharmaceutical profits
thanks to increased demand for personal protective
equipment (PPE), medical supplies, and treatments for
COVID-19. Operation Warp Speed for instance,
initiated by the Trump administration, funneled $18
billion to these areas (Kim et al., 2021). Despite being
partly taxpayer-funded, the innovative COVID-19
vaccines have led to enormous corporate profits and
wealth for their shareholders. One strategy to increase
vaccine uptake has been to offer it for free at the point
of service. However, these multinational companies
are not losing money on the administration of COVID19 vaccines. Instead, vaccine costs are passed on
indirectly and certain wealthy people become
wealthier. Mainstream media reporting has covered
many individuals who became billionaires thanks to
profits related to the COVID-19 pandemic. For
instance, vaccine sales led to Moderna having a
profitable quarter for the first time in 2021, and their
CEO Stephane Bancel, along with BioNTech CEO
Ugur Sahin, are among the new billionaires (Ziady,
2021). Such wealth concentration being an outcome of
the coronavirus pandemic could undoubtedly
contribute to public distrust, considering the untold
suffering among those unable to earn enough for an
adequate standard of living both during lockdown
restrictions and during “life as normal.”
Furthermore, concerns about side effects have
also contributed to COVID-19 vaccine hesitancy,
along with concerns regarding possible long-term
effects. According to the CDC, Adverse events related
to COVID-19 vaccines which are available in the U.S.
include anaphylaxis, Guillain-Barré syndrome,
myocarditis, pericarditis, and thrombocytopenia
syndrome (2021b). A relative lack of transparency
from the official Vaccine Adverse Event Reporting
System (VAERS), evident by the inaccessibility of its
user interface, has led to alternative avenues to fill the
desire of the public for information, such as the

Spectra Undergraduate Research Journal – 2022 – Volume 2, Issue 2

6

NARATIVE REVIEW OF COVID-19 VACCINE HESITANCY

OpenVAERS Project (OpenVAERS, 2021). Although
serious side effects are uncommon, the instances in
which they happen are nonetheless tragic. The National
Vaccine Injury Compensation Program (VICP) and
Countermeasures Injury Compensation Program
(CICP) shield vaccine manufacturers from liability
related to their products while providing some
restitution for victims (HRSA US DHHS, 2021).
However, these legal battles can be lengthy and
burdensome, causing significant stress on those
affected as well as their families, even if the decision is
ultimately settled in their favor (Bridges, 2016).
Considering that a trusted primary care
provider could assuage vaccine hesitancy concerns, the
issue of adequate services for rare victims of vaccine
injury can be framed within the context of healthcare
access and quality, an objective of Healthy People
2030. It is no secret that affordable, comprehensive
healthcare services remain out of reach for millions of
Americans who are uninsured or underinsured. When
the coronavirus pandemic struck, resources were
allocated to many public needs. Yet this basic need
remains unfulfilled, posing an ongoing threat to public
health related to COVID-19 and to innumerable other
health-related outcomes.
As the title suggests, an article in the American
Journal of Public Health outlined strategies for
“Building Trust in COVID-19 Vaccines and Beyond
Through Authentic Community Investment.” The
drive to get needles in arms, as it is sometimes stated,
is in service of public health. However, this goal may
overlook the chronic, ongoing public health crises
which receive less funding and focused attention. Over
time, this neglect and decay can lead to an
understandable erosion of trust.
Most recently updated in December 2020, the
Center for Preparedness and Response at the CDC
recommends these seven factors for consideration of
health communication messages:
1. Trust: Will people trust the information? Who is
the best source to put the information out?
2. Information: What information is necessary, and
how will people find it? How much is enough, or
too much?
3. Motivation: How relevant is the information to the
people we’re trying to reach?

4. Environment: What are the conditions that
surround and affect the audience?
5. Capacity: What is people’s ability to act on the
information? Are there barriers?
6. Perception: What will the audience think about the
information? What will inspire them to act on it?
7. Response: How will people respond? What can we
do to stay engaged with them and give them
support as they take action?
Here again, the theme of trust. Trust is not freely
given but earned. The scientific method, peer review
process, and general integrity of public health
institutions and universities are often lauded under the
umbrella of science itself: “Trust the science.” Those
who reduce the debate of vaccine hesitancy to the
aphorism, “Trust the science” may benefit from the
perspective that eugenics was once widely respected
and accepted as sound science and public health
practice. Segregation, redlining, anti-miscegenation,
and even forced sterilization were all sanctioned by the
U.S. government within the last century. Given the
sociopolitical context and historical evidence of human
rights abuses, a questioning attitude may be
understandable and may partially account for the
prevalence of vaccine hesitancy in the Black or
African-American population throughout the U.S.
Education has also been identified as a determinant
of public health and COVID-19 vaccine hesitancy.
Generally, individuals who have attained a lower level
of education tend to be more hesitant, or more likely to
reject the vaccine. Given the skyrocketing costs of
higher education, the perceived divide between the
“everyman” and elites may breed distrust of
institutions associated with these elites: mainstream
media, multinational corporations, universities, and
government bodies. While many may defer to
representatives of these institutions, others may
consider their perspective to be fruit from the
poisonous tree.
Furthermore, much of the communication related
to COVID-19 vaccination does not explain
calculations or define statistical terms such as absolute
risk reduction or number needed to treat. Instead, much
mainstream messaging distills complexities to easily
digestible bits of information or sound bites. Since
much of the public is aware that study design and
statistics can be manipulated, this may lead to quick
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rejection of authoritative information for lacking in
nuance. Additionally, this could lead to an information
void that can be easily filled with misinformation or
disinformation. Study authors or other parties may
consider health and science communication that
thoroughly explains such concepts while showing the
calculations involved, in order to demonstrate
transparency and to build trust. Comparison of the
COVID-19 vaccines to other, more widely accepted
vaccines could perhaps build confidence as well.
Immunization is undoubtedly one of the most
remarkable categories of public health intervention,
and its global adoption has saved countless lives. For
example, smallpox has been eradicated and polio has
nearly been eradicated. Compulsory smallpox
vaccination forms the legal precedent for mandatory
vaccination at public schools and by public employers,
based on U.S. Supreme Court rulings in Jacobson v.
Massachusetts (1905) and Zucht v. King (1922).
Furthermore, vaccine hesitancy has existed since the
variolation technique for smallpox was developed and
is expected to persist. Recent legal challenges have
arisen to address efforts of the Biden Administration to
create legal backing for COVID-19 vaccine mandates
in workplaces (BST Holdings, LLC v. OSHA, 2021).
Vaccine mandates can increase vaccine uptake, but
they may not increase trust.
In
this
challenging
environment
for
communication, interventions should be culturally
appropriate and tailored to address the barriers and
concerns of a given population. Those who are willing
to receive a vaccine but deterred by transportation and
cost may be most easily persuaded when those
obstacles are ameliorated. Those on the extreme end of
the spectrum may refuse all vaccinations and are highly
unlikely to ever accept a COVID-19 vaccination.
Surveillance and outreach to historically underserved,
low-income, and faith-based communities, as well as
different types of healthcare workers, may be insightful
in informing the growing body of research and in the
development of targeted, culturally appropriate
interventions for vaccine hesitancy. As previously
mentioned, healthcare workers can serve as
community-based messengers and counselors.
However, considering some high hesitancy rates
among this population, more than a one-hour training

session may be necessary (Meyer, Gjorgjjeva, &
Rosica, 2021).
To address the public health threat of COVID-19
with the goal of elimination, multi-pronged strategies
must be utilized. Primary intervention strategies
include environmental and engineering modifications
such as physical barriers and increased ventilation,
social distancing, facial covering, vaccination, and
other possible methods of prophylaxis. Increasing
protective factors related to general health status (e.g.,
nutrition, physical activity, cessation of cigarettes or
vape use) would also reasonably reduce the burden of
COVID-19 while increasing quality of life and
decreasing healthcare costs. Secondary intervention
strategies would include widespread testing to identify
asymptomatic and pre-symptomatic cases in
unvaccinated individuals, as well as in those who are
vaccinated. These measures along with providing
testing and paid sick leave related to coronavirus
disease and vaccination may also increase acceptance
while reducing financial burdens.
In conclusion, COVID-19 vaccine hesitancy
continues to be an obstacle in the way of eliminating
the disease. While vaccine mandates will likely save
lives from the prevention of COVID-19, they may also
feasibly contribute to diminished trust in health
authorities and deepen the sociopolitical divide.
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Appendix A: Figure 1. COVID-19 vaccine hesitancy with a focus on determinants adapted PRISMA flow
diagram

Identification

Identification of studies via PubMed National Institutes of Health database

Records identified from Medline
(PubMed) & CINAHL:
Databases
(n = 84)

Records screened
(n = 30)

Records removed before
screening abstract:
Duplicate records removed (n
= 9)
Records removed for
apparent irrelevance based
on title (n = 45)

Records excluded with automatic
tools**
(n = 0)
Records excluded from
screening abstract: (n = 16)

Screening

Reports sought for retrieval
(n = 14)

Included

Reports assessed for eligibility
(n = 14)

Reports not retrieved
(n = 0)

Reports excluded:
Reason 1 – not conducted in
2021 (n = 7)
Reason 2 – not related to
COVID-19 risk
communication (n = 2)
Reason 3 – not in English
(n =1)

Studies included in the review
(n = 4)

Note. *Consider, if feasible to do so, reporting the number of records identified from each database or register
searched (rather than the total number across all databases/registers).
**If automation tools were used, indicate how many records were excluded by a human and how many were
excluded by automation tools.
From: Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020
statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71.
https://doi.org/10.1136/bmj.n71
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Appendix B: Figure 2. COVID-19 vaccine hesitancy with a focus on risk communication adapted PRISMA
flow diagram

Identification

Identification of studies via PubMed National Institutes of Health database

Records identified from Medline
(PubMed) & CINAHL:
Databases
(n = 49)

Records screened
(n = 22)

Records removed before
screening abstract:
Duplicate records removed
(n = 10)
Records removed for
apparent irrelevance based
on title (n = 17)

Records excluded with automatic
tools**
(n = 0)
Records excluded from
screening abstract: (n = 3)

Screening

Reports sought for retrieval
(n = 19)

Included

Reports assessed for eligibility
(n = 19)

Reports not retrieved
(n = 0)

Reports excluded:
Reason 1 – not conducted in
2021 (n = 8)
Reason 2 – not related to
COVID-19 risk
communication (n = 3)
Reason 3 – not in English
(n =1)

Studies included in the review
(n = 4)

Note. * Consider, if feasible to do so, reporting the number of records identified from each database or register
searched (rather than the total number across all databases/registers).
**If automation tools were used, indicate how many records were excluded by a human and how many were
excluded by automation tools.
From: Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020
statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71.
https://doi.org/10.1136/bmj.n71
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Appendix C: Figure 3. COVID-19 vaccine hesitancy with a focus on risk communication adapted PRISMA
flow diagram

Identification

Identification of studies via PubMed National Institutes of Health database

Records identified from Medline
(PubMed) & CINAHL:
Databases

Records removed before
screening abstract:
Duplicate records removed
(n = 6)
Records removed for
apparent irrelevance based
on title (n = 55)

(n = 106)

Records screened
(n = 45)

Records excluded with automatic
tools**
(n = 0)
Records excluded from
screening abstract: (n = 3)

Screening

Reports sought for retrieval
(n = 42)

Included

Reports assessed for eligibility
(n = 41)

Reports not retrieved - retracted
(n = 1)

Reports excluded:
Reason 1 – not conducted in
2021 (n = 16)
Reason 2 – not national in
scope (n = 15)
Reason 3 – not adults,
population of interest
(n =4)

Articles included in the review
(n = 5)
Article retrieved as part 2 of an
included article (n =1)

Note. * Consider, if feasible to do so, reporting the number of records identified from each database or register
searched (rather than the total number across all databases/registers).
**If automation tools were used, indicate how many records were excluded by a human and how many were
excluded by automation tools.
From: Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020
statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71.
https://doi.org/10.1136/bmj.n71
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Appendix D: Table 1. Summary of studies related to determinants of COVID-19 vaccine hesitancy
Authors, Year

Population & Sample

Agley, Xiao,
Thompson, &
GolzarriArroyo

U.S. adults

Published July 2021

n = 953

*redirected from the
search for
interventions

Nationally
representative sample

Theory used, if
any
Mentioned:
Nadelson’s
concept of trust in
science and
scientists

Design
Crosssectional
exploratory study

Determinants
studied
Demographics
Previous COVID-19
diagnosis

Online survey
through research
panel service

Trust in science

January 22-24,
2021

Religious
commitment

Black and African-American people
more likely to report hesitance
Perceived susceptibility, prior COVID19 diagnosis, and family/friend
avoidance of crowds not powerful
predictors

Political affiliation

Perceived severity of
and susceptibility to
COVID-9
Family/friend
avoidance of
crowded settings
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Salient findings

Perceived severity of COVID-19
significantly associated with higher
vaccine acceptance
Higher trust in science associated with
higher vaccine acceptance
Conservative ideology associated with
lower vaccine acceptance
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Zheng, Jiang, & Wu

U.S. adults

Mentioned:

Crosssectional survey

Published in
September 2021

Nationally
representative sample

Knowledge,
attitude, behavior
theory

Online survey
through Qualtrics

*redirected from the
search for risk
communication

n = 800
Secondary risk
theory

February 5-23,
2021

Diffusion of
innovation theory

Demographics
Perceived
susceptibility to
COVID-19 vaccine
side effects

Age (p < 0.001), education (p = 0.004),
income (p = 0.003), and general health
status (p = 0.001) associated with
intention to vaccinate
Female gender negatively associated
with intention to vaccinate (p=0.001)

Perceived severity of
COVID-19 vaccine
side effects

Race did not predict intention to
vaccinate

Knowledge related to
COVID-19 vaccines

COVID-19 vaccines knowledge not
strongly related to vaccine acceptance

Doctor-patient
relationship

No impact of perceived severity of
COVID-19 on vaccine acceptance

Vaccination intention

Susceptibility to COVID-19 vaccine side
effects predicted lower vaccine
acceptance
Knowledge did not directly predict
vaccine acceptance, although it did
influence perceived susceptibility to
COVID-19 infection

Tram, Saeed, Bradley,
Fox, Eshun-Wilson,
Mody, & Geng
Published July 2021

U.S. adults

Mentioned:

Nationally
representative and state
representative sample

Health belief
model

n = 459,235

Moral
foundations
theory

Biweekly crosssectional survey, 6
survey periods
January 6 - March
29, 2021
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Demographics
Reasoning for
hesitancy:
Deliberation
Distrust

Perceived susceptibility to COVID-19
vaccine side effects was lower with
greater vaccine knowledge and improved
doctor-patient communication
Vaccine hesitancy remained mostly
unchanged over the course of the study
Highest prevalence of vaccine hesitancy
in these groups:
• Female sex (19.2%)
• Age groups 25-39 years (25.2%)
and 40-54 years (21.6%)
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4C model
Rogers diffusion
of innovations
theory

An online survey,
contact established
via email, and/or
text message

•

Dissent
•
•

•

•

Americans who are Black
(25.8%) and multiracial (>2
races reported, 26.0%)
White Americans residing in
Southern and Mountain states
Lower income: as income
increases, hesitancy decreases
<$25,000/year (25.9%)
$25-34,999 (21.3%)
$35-49,999 (19.4%)
$50-74,999 (17.1%)
$75-99,999 (16.9%)
$100-149,999 (13.6%)
$150-199,999 (10.3%)
>$200,000 (7.9%)
Less education
< High school (24.1%)
Some college (20%)
> Bachelor’s (9.6%)
Republican-leaning states

Older age groups, Hispanic ethnicity,
Asian race, college education, and higher
income variables associated with greater
vaccine acceptance
Vaccine rejection or refusal associated
with more expressed distrust and dissent
reasons for hesitancy
Deliberation associated with fewer
expressed reasons and less strong
hesitancy
Conservative ideology a stronger
determinant of vaccine hesitancy for
White people than for Black people
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Kreps, Goldfarb,
Brownstein, & Kriner
Published August 2021

U.S. adults

None mentioned

Nationally
representative sample

Crosssectional study
Survey related to
Moderna and
PfizerBioNTech
vaccines,
conducted online
and by phone
February 11-15,
2021

n = 1,027

Demographics
Perceived side effect
severity
Knowledge: Size of
COVID-19 vaccine
clinical trials
Knowledge: Whether
the mRNA vaccines
contain live
coronavirus
Hesitancy:
Willingness to
receive a COVID-19
vaccine (4-point
Likert scale)

Li & Li

U.S. adults

3Cs model:

Published May 2021

Nationally
representative sample

Convenience
Complacency
Confidence

CrossSectional study
JanuaryMarch 2021

n = 443,680

Demographics
Adapted 3Cs:
Confidence
Complacency
Circumspection

40% perceived side effects to be severe
or somewhat severe
• More common among those who
expressed hesitancy than those
who expressed willingness to
receive a vaccine
• Republicans and Black
Americans significantly more
likely to express perception of
severe side effects (p < 0.01 for
both)
Small portion (15%) accurately estimated
clinical trial size (participants >50,000)
• Underestimation more common
among those who expressed
hesitancy
Small difference between respondents
who believe there is live coronavirus
present in mRNA vaccines
• Those willing to be vaccinated
were more likely to correctly
state that live coronavirus is not
present in the mRNA vaccines
Women more likely to report hesitancy
for circumspection reasons
Men more likely to report hesitancy for
complacency reasons
Hesitancy among White people higher in
more conservative (Republican) states
Black people more likely to be hesitant
than White, Hispanic, and Asian people
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Eshun-Wilson, Mody
Tram, Bradley, Sheve,
Fox, Thompson, Geng,
& Mody

U.S. adults

Published August 2021

n = 2,985

Nationally
representative sample

Rational utility
theory

Discrete choice
experiment

Rational choice
theory

March 15-22, 2021

None mentioned

Cross sectional
study

Social determinants
of health

National
vaccination data as
of
April 19, 2021

Political ideology

*redirected from
search for literature on
interventions

Agarwal, Dugas,
Ramaprasad, Li, &
Gao
Published July 2021

U.S. adults
Data from 756
counties, representing
170.6 million
individuals or 51% of
national population
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Demographics
Preferences related to
vaccination:
Status, intention
Site
Waiting time
Number of doses
Need for annual
booster
Community
vaccination
acceptance
Voluntary or
compulsory
compliance

Vaccination uptake

Increased accessibility not likely to
increase to full acceptance
Preferences:
• Single dose preferred over multiple
• Short waiting time
• Vaccination in healthcare settings
rather than mass vaccination sites
• Concerns about waiting time,
location
• “Wait and see” hesitators increased
likelihood to vaccinate if required for
work, school, air travel, etc.
• Resistant groups, more likely to be
Republicans, Black or AfricanAmerican, not swayed by
convenience or mandates for
activities
• Older adults, Democrats, White and
Asian people more likely to accept
vaccination and be influenced by
convenience and enforcement
strategies
Lower median income (individual) and
greater vote share for the Republican
party in the 2020 general election (state
level) was associated with less vaccine
uptake
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Appendix E: Table 2. Summary of articles related to COVID-19 vaccine hesitancy interventions with a focus on risk communication
Authors, Year

Type of article

Concerns identified

Recommendations

Rosenbaum

Commentary

Attempts to alter vaccine hesitancy can further
entrench resistance

Acknowledge unknowns as part of the scientific process

Published April 8, 2021
Long-term safety is a legitimate concern
If authorities are not trusted, members of the public
may disregard evidence and health guidance

Encourage open dialogue in order to discourage reliance
on questionable sources of information
Demonstrate empathy

Censorship may embolden those who spread
misinformation
Taboo against healthy skepticism may hinder sincere
conversation
Indifference toward adverse reactions to vaccines
Rosenbaum

Commentary

Heuristic thinking which prefers “natural” risks over
artificial or man-made risks

Contextualize scientific findings to acknowledge
limitations

Differing values and priorities may be identified as
broadly “anti-science”

Acknowledge humanity and personal values, especially
in actions related to life-or-death situations

Public interpretation of scientific findings is filtered
through the perception of the messenger(s)

Genuine doctor-patient relationships may be able to
counter vaccine hesitancy

Published April 15, 2021

Trust in the broader system of government may be a
proxy for trust in COVID-19 vaccines
Hoetz

Viewpoint

2021
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Outreach from scientists and physician-scientists
Appearance on conservative news outlets to reach the
target audience, reduce division
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Federal interagency task force to identify and counter
anti-science groups
Sauer, Truelove, Gerste,
& Limaye

Commentary

Delayed commentary on events can lead to fear and
information void that can be filled by untrustworthy
sources

2021
Inconsistent messaging
Lack of credibility, perceived trustworthiness

Utilize 6 core principles of Crisis Emergency Risk
Communication (CERC) from CDC:
1. Be first
2. Be right
3. Be credible
4. Express empathy
5. Promote action
6. Show respect

Lack of demonstrated respect, concern or empathy
can diminish trust
Authorities who fail to follow health guidance
diminish trust
Diminished trust and credibility can reduce the
willingness of the public to implement health
guidance
Katzman & Katzman

Commentary

Diverse concerns of patients can contribute to varying Elicit appropriate emotion(s) in patients to motivate
levels of hesitancy
appropriate action(s)

Published March 2021
Minimal training for clinicians to address contentious
topics with patients

Project ECHO, one-hour training on COVID-19 vaccine
communication
Open discussions in-person or virtual settings to address
COVID-19 vaccination
Social media and influential individuals can be leveraged

Coustasse, Kimble, &
Maxik
2021

Letter to the
editor

Misinformation and perceptions related to safety,
regulatory process

Healthcare professionals promote transparency in
interpreting data, particularly related to adverse events

Disparities related to sex, race, age, educational
attainment, and income

Mandatory vaccination
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Reduced acceptance related to lack of trust,
compounded by political influences
Cervantes

Invited
commentary

Published September
2021

Lower vaccination rates among racial and ethnic
minorities, in particular Black and Latino groups
Vague information and misinformation, politicization
of COVID-19 information

*redirected from search
for literature on
determinants

Mistrust of the medical establishment, including the
pharmaceutical industry

Increase community engagement, involve stakeholders
Deploy community health workers to areas at greater risk
of vaccine hesitancy
Address structural racism and social determinants of
health (i.e., access to adequate healthcare services)

Unknowns related to cost, scheduling, and eligibility
Gayle & Childress

Guest editorial

Published 2021

Miller
Published 2021

Letters:
Viewpoints on
Current Issues

Racial and ethnic disparities related to COVID-19
vaccination and infection, including vulnerability of
essential workers

Ensure that allocation of vaccines is grounded in ethical
principles, including fairness, transparency, and basis in
evidence (evidence-based)

Co-morbidities among racial and ethnic minorities,
including those related to socioeconomic inequality

Campaigns to increase vaccine acceptance and uptake
that are tailored to the specific community concerns

Ineffective and inconsistent communication

Utilizing language that is positive and personalizes those
involved (i.e., scientists rather than institutions)

Concerns related to side effects
Emphasize impact on family rather than community
Lack of trust, particularly among marginalized and
underserved groups

Alter message to fit the target audience, considering age,
gender, race, and geography
Validate concerns and avoid lecturing

Pierce

Editorial

Inconsistencies among states in vaccine
communication and rollout

Published May/June 2021
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Invest in public health infrastructure to allow for
effective communication from experts

22

NARATIVE REVIEW OF COVID-19 VACCINE HESITANCY

Insufficient staffing and resources

Consistency in messaging

Lack of national education and promotion campaigns
for COVID-19 vaccines

Address health inequities and build trust in communities
of greatest need
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